Peer-reviewedCC BY-NC-ND 4.0The Australasian Journal of Dermatology
Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service
- 1Department of Dermatology Waikato Hospital, Health New Zealand Waikato Hamilton New Zealand
- 2Auckland University, Waikato Clinical Campus Hamilton New Zealand
Related
- Repeated Relapse–Retreatment Cycles After Omalizumab Withdrawal in Chronic Spontaneous Urticaria: A Real-World Study
- Evaluation of Fibromyalgia Frequency in Chronic Spontaneous Urticaria Patients Referred to a Tertiary Dermatology Outpatient Clinic.
- Treatment Choice and Cardiovascular Risk in Chronic Spontaneous Urticaria.
- Lower Serum SCCA2 Detectability in Chronic Spontaneous Compared with Chronic Inducible Urticaria: A Prospective Observational Study
- Efficacy and safety of acupuncture therapy for chronic spontaneous urticaria: a network meta-analysis based on randomized controlled trials
BibTeX
@article{lee2026realworld,
title = {{Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service}},
author = {Jeffrey Lee and Karen Koch},
journal = {The Australasian Journal of Dermatology},
year = {2026},
month = jul,
doi = {10.1111/ajd.70185},
url = {https://doi.org/10.1111/ajd.70185},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Real‐World Outcomes of Omalizumab for Chronic Spontaneous Urticaria in a New Zealand Regional Dermatology Service
AU - Jeffrey Lee
AU - Karen Koch
PY - 2026
DA - 2026/07/24
JO - The Australasian Journal of Dermatology
DO - 10.1111/ajd.70185
UR - https://doi.org/10.1111/ajd.70185
SN - 0004-8380
SN - 1440-0960
ER -